https://www.selleckchem.com/pr....oducts/etomoxir-na-s
The incidence of early major complications, including all-cause death and reoperation due to bleeding, was lower in the TT group. No significant differences were observed in the 7-year survival probability between the two groups. The encouraging results regarding the perioperative and long-term outcomes of patients who underwent a TT re-MVR show that this approach is particularly beneficial for patients requiring reoperation. The encouraging results regarding the perioperative and long-term outcomes of patients who underwent a
Like
Comment
Share
